Heron Therapeutics Inc (HRTX)

EBITDA Margin

-18.53%

TTM · Period ending:

HRTX logo

HRTX EBITDA Margin

Latest reported-18.53%
HRTX TTM EBITDA Margin (-241.18% → -18.53%)
High-resolution chart · PNG

HRTX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-4.5977%
-12.4294%
-18.2796%
-29.7872%
-40.1099%
-44.9704%
-48.7654%
-44.7205%
-34.5912%
-39.5062%
-45.283%
-51.5723%
-52.5424%
-48.913%
-47.644%
-56.9697%
-62.4113%
-59.1667%
-58.2418%
-72.6027%
-84.9057%
-126.3158%
-135.4839%
-117.8571%
-103.2258%
-110%
-173.913%
-152%
-162.5%
-148%
-126.6667%
-86.2069%
-332.1429%
-268.9655%
-300%
-236%
-114.8148%
-141.6667%
-152.1739%
-241.1765%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.